Skip to main content

Table 2 Prevalence of superantigens among isolates with antibiotic resistance

From: Prevalence and distribution of resistance and enterotoxins/enterotoxin-like genes in different clinical isolates of coagulase-negative Staphylococcus

Antimicrobial susceptibility patterns Types of SAgs
S I R Antimicrobial agents SEA (n = 2) SEB (n = 25) SEC (n = 44) SED (n = 3) SEE (n = 11) SEH (n = 4) SEM (n = 5) TST1 (n = 23)
42 (46.2) 49 (53.8) Fox 2 13 28 0 5 2 4 13
49 (53.8) 42 (46.2) Sxt 2 12 22 1 2 2 3 11
62 (68.1) 3 (3.3) 26 (28.6) Ery 1 8 13 1 1 0 2 5
73 (80.2) 18 (19.8) Cli 0 4 7 0 2 1 0 2
64 (70.3) 4 (4.4) 23 (25.3) Chl 1 5 10 1 1 1 1 4
88 (96.7) 3 (3.3) Riph 0 3 1 0 1 1 0 0
80 (87.9) 11 (12.1) Levo 0 4 3 1 2 0 0 2
100 (100) 0 Vanco 0 0 0 0 0 0 0 0
65 (71.4) 6 (6.6) 20 (22) Gen 0 5 12 0 1 1 1 5
69 (75.8) 22 (24.2) Dox 0 4 10 1 3 0 1 3
86 (94.5) 5 (5.5) Novo 0 3 2 1 2 0 1 1
  1. Fox cefoxitin, Sxt trimethoprim-sulfamethoxazole, Ery erythromycin, Cli clindamycin, Chl chloramphenicol, Riph rifampicin, Levo levofloxacin, Van vancomycin, Gen gentamicin, Dox doxycycline, Novo novobiocin